October 2025
1. WALKER AE, Gao X, Wang Q, De la Cruz G, et al
   Prognostic significance of CD8+ T cell Spatial Biomarkers in ER+ and ER- breast cancer: A retrospective cohort study.
   PLoS Med. 2025;22:e1004647.
   

   >> Share

   
   July 2025
2. VOELSKOW V, Garcia-Albeniz X, Berglund A, Feychting M, et al
   Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trials.
   PLoS Med. 2025;22:e1004661.
   

   >> Share

   
   
3. ZHANG J, Meng Y, Wang B, Wu X, et al
   Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.
   PLoS Med. 2025;22:e1004669.
   

   >> Share

   
   December 2024
4. DUNN MR, Li D, Emerson MA, Thompson CA, et al
   A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness.
   PLoS Med. 2024;21:e1004500.
   

   >> Share

   
   August 2024
5. HELGESTAD ADL, Larsen MB, Njor S, Tranberg M, et al
   Increasing coverage in cervical and colorectal cancer screening by leveraging attendance at breast cancer screening: A cluster-randomised, crossover trial.
   PLoS Med. 2024;21:e1004431.
   

   >> Share

   
   May 2024
6. MOORE-PALHARES D, Dasgupta A, Saifuddin M, Anzola Pena ML, et al
   Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: A Phase 1 clinical trial.
   PLoS Med. 2024;21:e1004408.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share